Study ID (surname of first author and year published) | |||
Study characteristics | Descriptions (include comparative information for each intervention or comparison group if available) | Further details | Source (pg and/ fig/table/other) |
Single centre/Multi‐centre | |||
Start and end dates of data collection | |||
Duration of participation (from recruitment to last follow‐up) | |||
Power (e.g. power and sample size calculation, level of power achieved) | |||
Notes: | |||
Participant characteristics (record all reported measures) | |||
Population description (from which study participants were drawn) | |||
Setting (include location) | |||
Inclusion criteria | |||
Exclusion criteria | |||
Method of recruitment (e.g. phone, mail, clinic patients) | |||
Total no. randomly assigned | |||
Baseline imbalances | |||
Withdrawals and exclusions | |||
Age | |||
Sex | |||
BMI | |||
No. of participants in each group | Intervention 1:_____ ; Intervention 2:_____ Control 1: _____; Control 2: _____ |
||
No. of participants who received intended treatment | Intervention 1: _____ ; Intervention 2:_____ Control 1:_____; Control 2:______ |
||
No. of participants who were analysed | Intervention 1: _____; Intervention 2:_____ Control 1:______; Control 2:______ |
||
Notes: | |||
Interventions | |||
Intervention group 1 | |||
FNB technique and type (i.e. continuous or single‐shot FNB) | |||
Additional blocks (i.e. sciatic or obturator) | |||
Description of FNB (include type of drug, dosage and regimen used) | |||
Duration of treatment period | |||
PCA opioid in FNB group? | Yes/No. If yes, describe | ||
Type of co‐analgesia/Supplemental analgesia | |||
Loss to follow‐up | |||
Others | |||
Intervention group 2 | |||
FNB technique and type (i.e. continuous or single‐shot FNB) | |||
Additional blocks (i.e. sciatic or obturator) | |||
Description of FNB (include type of drug, dosage and regimen used) | |||
Duration of treatment period | |||
PCA opioid in FNB group? | Yes/No. If yes, describe | ||
Type of co‐analgesia/Supplemental analgesia | |||
Loss to follow‐up | |||
Others | |||
Control group 1 | |||
Technique and type (i.e. PCA, epidural, infiltration +/‐ intra‐articular injection, oral or placebo) | |||
Drugs, dosage and regimen used | |||
Placebo block in PCA group? | Yes/No. If yes, describe | ||
Type of co‐analgesia/Supplemental analgesia | |||
Loss to follow‐up | |||
Others | |||
Control group 2 | |||
Technique and type (i.e. PCA, epidural, infiltration +/‐ intra‐articular injection, oral or placebo) | |||
Drugs, dosage and regimen used | |||
Placebo block in PCA group? | Yes/No. If yes, describe | ||
Type of co‐analgesia/Supplemental analgesia | |||
Loss to follow‐up | |||
Others |